dalteparin has been researched along with Placenta Accreta in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Placenta Accreta: Abnormal placentation in which all or parts of the PLACENTA are attached directly to the MYOMETRIUM due to a complete or partial absence of DECIDUA. It is associated with POSTPARTUM HEMORRHAGE because of the failure of placental separation.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Einerson, BD | 1 |
| Branch, DW | 1 |
1 review available for dalteparin and Placenta Accreta
| Article | Year |
|---|---|
Surgical Management of Placenta Accreta Spectrum.
Topics: Anticoagulants; Cesarean Section; Enoxaparin; Female; Gestational Age; Humans; Hysterectomy; Magneti | 2018 |